Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

336 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis.
Menendez JA, Lupu R. Menendez JA, et al. Nat Rev Cancer. 2007 Oct;7(10):763-77. doi: 10.1038/nrc2222. Nat Rev Cancer. 2007. PMID: 17882277 Review.
Mediterranean diet, olive oil and cancer.
Colomer R, Menéndez JA. Colomer R, et al. Among authors: menendez ja. Clin Transl Oncol. 2006 Jan;8(1):15-21. doi: 10.1007/s12094-006-0090-0. Clin Transl Oncol. 2006. PMID: 16632435 Review.
Oncogenic properties of the endogenous fatty acid metabolism: molecular pathology of fatty acid synthase in cancer cells.
Menendez JA, Lupu R. Menendez JA, et al. Curr Opin Clin Nutr Metab Care. 2006 Jul;9(4):346-57. doi: 10.1097/01.mco.0000232893.21050.15. Curr Opin Clin Nutr Metab Care. 2006. PMID: 16778562 Review.
HER2 (erbB-2)-targeted effects of the omega-3 polyunsaturated fatty acid, alpha-linolenic acid (ALA; 18:3n-3), in breast cancer cells: the "fat features" of the "Mediterranean diet" as an "anti-HER2 cocktail".
Menéndez JA, Vázquez-Martín A, Ropero S, Colomer R, Lupu R. Menéndez JA, et al. Clin Transl Oncol. 2006 Nov;8(11):812-20. doi: 10.1007/s12094-006-0137-2. Clin Transl Oncol. 2006. PMID: 17134970
Mediterranean dietary traditions for the molecular treatment of human cancer: anti-oncogenic actions of the main olive oil's monounsaturated fatty acid oleic acid (18:1n-9).
Menendez JA, Lupu R. Menendez JA, et al. Curr Pharm Biotechnol. 2006 Dec;7(6):495-502. doi: 10.2174/138920106779116900. Curr Pharm Biotechnol. 2006. PMID: 17168666 Review.
Protein array technology to detect HER2 (erbB-2)-induced 'cytokine signature' in breast cancer.
Vazquez-Martin A, Colomer R, Menendez JA. Vazquez-Martin A, et al. Among authors: menendez ja. Eur J Cancer. 2007 May;43(7):1117-24. doi: 10.1016/j.ejca.2007.01.037. Epub 2007 Mar 26. Eur J Cancer. 2007. PMID: 17379503
Olive oil's bitter principle reverses acquired autoresistance to trastuzumab (Herceptin) in HER2-overexpressing breast cancer cells.
Menendez JA, Vazquez-Martin A, Colomer R, Brunet J, Carrasco-Pancorbo A, Garcia-Villalba R, Fernandez-Gutierrez A, Segura-Carretero A. Menendez JA, et al. BMC Cancer. 2007 May 9;7:80. doi: 10.1186/1471-2407-7-80. BMC Cancer. 2007. PMID: 17490486 Free PMC article.
An update of the mechanisms of resistance to EGFR-tyrosine kinase inhibitors in breast cancer: Gefitinib (Iressa) -induced changes in the expression and nucleo-cytoplasmic trafficking of HER-ligands (Review).
Ferrer-Soler L, Vazquez-Martin A, Brunet J, Menendez JA, De Llorens R, Colomer R. Ferrer-Soler L, et al. Among authors: menendez ja. Int J Mol Med. 2007 Jul;20(1):3-10. Int J Mol Med. 2007. PMID: 17549382 Review.
BRCA1 and acetyl-CoA carboxylase: the metabolic syndrome of breast cancer.
Brunet J, Vazquez-Martin A, Colomer R, Graña-Suarez B, Martin-Castillo B, Menendez JA. Brunet J, et al. Among authors: menendez ja. Mol Carcinog. 2008 Feb;47(2):157-63. doi: 10.1002/mc.20364. Mol Carcinog. 2008. PMID: 17620310
Pharmacological blockade of fatty acid synthase (FASN) reverses acquired autoresistance to trastuzumab (Herceptin by transcriptionally inhibiting 'HER2 super-expression' occurring in high-dose trastuzumab-conditioned SKBR3/Tzb100 breast cancer cells.
Vazquez-Martin A, Colomer R, Brunet J, Menendez JA. Vazquez-Martin A, et al. Among authors: menendez ja. Int J Oncol. 2007 Oct;31(4):769-76. Int J Oncol. 2007. PMID: 17786307
336 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback